Skip to main content
Unknown status

Trimodality Therapy for Malignant Pleural Mesothelioma

By April 24, 2017No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 200

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Observational

Study Design Allocation: Observational Model: Cohort|Time Perspective: Prospective

Study ID Numbers: RP2002-01

Study First Received: April 5, 2011

Last Updated: April 26, 2011

Estimated Primary Completion Date: December 2012

 

Primary Outcome Measures:

To determine the overall 5-year survival rate.|Number of Participants with Adverse Events as a Measure of Safety and Tolerability|Number of Participants with treatment related deaths as a Measure of Safety and Tolerability|Recurrence

Sponsors and Collaborators:

HSK Wiesbaden

Website Link: https://ClinicalTrials.gov/show/NCT01343264

Leave a Reply